Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,870 public trials 2,109 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Completed

A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC)

NCT03412773

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Providence Medical Foundation Fullerton, California, United States
  • UCLA Hematologyoncology Los Angeles, California, United States
  • Chao Family Comprehensive Cancer Center Orange, California, United States
  • Massachusetts General Hospital Boston, Massachusetts, United States
View all 122 locations
View Trial Details
Completed

A Study of MGC018 in Combination With MGD019 in Participants With Advanced Solid Tumors

NCT05293496

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Solid Tumor, +53 more
Locations
  • University of California, Los Angeles Los Angeles, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • Florida Cancer Specialists and Research Institute Sarasota, Florida, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
View Trial Details
Completed

Pembrolizumab in Combination With CRT for LA-SCCHN

NCT02586207

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Cancer, +25 more
Locations
  • UCSD Moores Cancer Center La Jolla, California, United States
  • Sanford-Bismarck Medical Center Bismarck, North Dakota, United States
  • Sanford-Roger Maris Cancer Center Fargo, North Dakota, United States
  • Sanford Health Cancer Center Sioux Falls, South Dakota, United States
View Trial Details
Completed

Safety and Preliminary Effectiveness of BGB-A445 in Combination With Tislelizumab in Participants With Advanced Solid Tumors

NCT04215978

Conditions
Advanced Solid Tumor, Bronchial Neoplasms, Carcinoma, +25 more
Locations
  • Valkyrie Clinical Trials Los Angeles, California, United States
  • California Cancer Associates for Research & Excellence (cCARE) San Diego, California, United States
  • UPMC Hillman Cancer Center (Univ Of Pittsburgh) Pittsburgh, Pennsylvania, United States
  • Blacktown Cancer And Haematology Centre Blacktown, New South Wales, Australia
View all 30 locations
View Trial Details
Completed

A Study of Pemigatinib in Non-muscle Invasive Bladder Cancer Patients With Recurrent Low- or Intermediate-Risk Tumors

NCT03914794

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +17 more
Locations
  • Sibley Memorial Hospital Washington D.C., District of Columbia, United States
  • Johns Hopkins School of Medicine - Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
  • Associated Medical Professionals Urology Syracuse, New York, United States
  • Midlantic Urology Bala-Cynwyd, Pennsylvania, United States
View Trial Details

Related conditions